Researchers Submit Patent Application, 'Predictive Test For Identification Of Early Stage Nsclc Stage Patients At High Risk Of Recurrence After Surgery', for Approval (USPTO 20220341939)

2022 NOV 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors MAGUIRE, Laura [...]